PTC
Philadelphia Trust Company Portfolio holdings
AUM
$1.3B
1-Year Return
27.2%
This Quarter Return
+18.55%
1 Year Return
+27.2%
3 Year Return
+125.8%
5 Year Return
+214.19%
10 Year Return
+423.79%
AUM
$1.3B
AUM Growth
+$135M
(+12%)
Cap. Flow
-$34.3M
Cap. Flow
% of AUM
-2.63%
Top 10 Holdings %
Top 10 Hldgs %
43.54%
Holding
257
New
15
Increased
40
Reduced
83
Closed
13
Top Buys
| 1 |
Becton Dickinson
BDX
|
+$4.74M |
| 2 |
Chart Industries
GTLS
|
+$4.12M |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.92M |
| 4 |
D.R. Horton
DHI
|
+$2.53M |
| 5 |
CRISPR Therapeutics
CRSP
|
+$2.44M |
Top Sells
| 1 |
PayPal
PYPL
|
+$11.3M |
| 2 |
Vertiv
VRT
|
+$9.83M |
| 3 |
Medtronic
MDT
|
+$6.97M |
| 4 |
NVIDIA
NVDA
|
+$5.92M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$4.26M |
Sector Composition
| 1 | Technology | 37.19% |
| 2 | Industrials | 15.05% |
| 3 | Healthcare | 11.06% |
| 4 | Financials | 10.51% |
| 5 | Communication Services | 6.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Philip Morris
PM
$256B
| $5.28M | 0.4% |
28,961
-2,394
| -8% | -$436K |
|
52
Donegal Group Class A
DGICA
$704M
| $5.12M | 0.39% |
255,740
-250
| -0.1% | -$5.01K |
|
53
Vanguard Mid-Cap ETF
VO
$87.4B
| $4.58M | 0.35% |
16,355
| – | – |
|
54
Vanguard Dividend Appreciation ETF
VIG
$96.1B
| $4.57M | 0.35% |
22,343
-645
| -3% | -$132K |
|
55
Neurocrine Biosciences
NBIX
$14.3B
| $4.36M | 0.33% |
34,660
| – | – |
|
56
Permian Resources
PR
$9.66B
| $4.35M | 0.33% |
319,250
+5,000
| +2% | +$68.1K |
|
|
57
Medtronic
MDT
$121B
| $4.24M | 0.33% |
48,604
-79,982
| -62% | -$6.97M |
|
58
Graham Corp
GHM
$521M
| $4.19M | 0.32% |
84,532
+24,754
| +41% | +$1.23M |
|
59
Johnson & Johnson
JNJ
$426B
| $4.18M | 0.32% |
27,340
| – | – |
|
60
Merck
MRK
$211B
| $4.17M | 0.32% |
52,691
-275
| -0.5% | -$21.8K |
|
61
iShares Russell 1000 ETF
IWB
$44.1B
| $4.06M | 0.31% |
11,946
| – | – |
|
62
STAG Industrial
STAG
$6.75B
| $3.73M | 0.29% |
102,860
-1,123
| -1% | -$40.7K |
|
63
Tidewater
TDW
$2.89B
| $3.52M | 0.27% |
76,203
-7,064
| -8% | -$326K |
|
64
iShares US Aerospace & Defense ETF
ITA
$9.21B
| $3.48M | 0.27% |
18,424
-58
| -0.3% | -$10.9K |
|
65
Elanco Animal Health
ELAN
$9.32B
| $3.39M | 0.26% |
237,538
+6,642
| +3% | +$94.8K |
|
66
Eli Lilly
LLY
$673B
| $3.3M | 0.25% |
4,233
-2
| -0% | -$1.56K |
|
67
Parke Bancorp
PKBK
$269M
| $3.3M | 0.25% |
161,830
| – | – |
|
68
Vanguard S&P 500 Growth ETF
VOOG
$19.5B
| $3.11M | 0.24% |
7,842
| – | – |
|
69
Cigna
CI
$80.6B
| $3.06M | 0.23% |
9,263
| – | – |
|
70
EQT Corp
EQT
$31.4B
| $3.02M | 0.23% |
51,811
-2,560
| -5% | -$149K |
|
71
Nike
NKE
$109B
| $2.97M | 0.23% |
41,799
+7,358
| +21% | +$523K |
|
72
GSK
GSK
$82.1B
| $2.54M | 0.19% |
66,140
-644
| -1% | -$24.7K |
|
|
73
CRISPR Therapeutics
CRSP
$4.88B
| $2.44M | 0.19% |
+50,250
| New | +$2.44M |
|
74
GE Aerospace
GE
$293B
| $2.32M | 0.18% |
9,025
| – | – |
|
75
Sprott Physical Gold and Silver Trust
CEF
$6.53B
| $2.25M | 0.17% |
74,676
-3,768
| -5% | -$113K |
|